440
Last Update Posted: 2005-06-24
Recruiting has ended
All Genders accepted | 18 Years-55 Years |
124 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Sertraline and Naltrexone for Alcohol Dependence
This study is a double-blind, placebo-controlled outpatient trial to improve, through the addition of sertraline (Zoloft), the abstinence and relapse rates in alcohol- dependent individuals currently taking naltrexone (Revia).
Eligibility
Relevant conditions:
Alcoholism
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov